Solid and non-solid tumors, tumor development, progression and therapy are addressed in this emphasis. Multiscale research from cells to humans is covered that focuses on the mechanistic investigation of cancer-related biological processes, probe development and novel diagnostic and therapeutic applications.
Probes & Targets
The design, chemical synthesis and characterization of imaging probes and theranostic agents as well as reporter genes used to study neoplastic diseases will be addressed. All imaging modalities will be covered.
All applications in oncology where new imaging tools, probes and therapeutics are evaluated on cells or animals belong to this category. It also includes the preclinical testing of image-guided therapies.
In this category, oncologic research will be presented that mainly addresses new biological mechanisms and where imaging is rather used as a tool to gain the mechanistic insights. New approaches in bioengineering and new disease models will be considered.
Translational and Human Studies
Oncology research on humans or (non-human) studies with demonstrated potential for clinical impact or immediate translation should be submitted to this category. It includes prospective and retrospective studies as well as studies on new pharmaceuticals at phase I-IV where imaging plays a significant role in the study. Studies on Omics and its combination with imaging are also welcome.